Status:
COMPLETED
A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety
Lead Sponsor:
UCB Pharma
Conditions:
ANXIETY
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This was a multicenter, open-label, randomized crossover trial comparing two treatments, Alprazolam ODT versus conventional alprazolam tablets, in subjects who were already taking conventional immedia...
Detailed Description
See approved Package Insert for Adverse Event information.
Eligibility Criteria
Inclusion
- Currently being treated with conventional alprazolam
Exclusion
- Dose of greater than 10 mg
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
November 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00139854
Start Date
August 1 2004
End Date
November 1 2004
Last Update
August 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schwarz
Milwaukee, Wisconsin, United States